Novakand Pharma AB (publ) (LARK) — Free Cash Flow Generation Index
Novakand Pharma AB (publ) (LARK) has a Free Cash Flow Generation Index of 1.00x as of June 2026. Free cash flow of Skr352.00K represents 1% of operating cash flow (Skr352.00K). Check LARK asset resilience ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Novakand Pharma AB (publ) Free Cash Flow Generation Index (2012–2021)
Historical FCF Generation Index trend for Novakand Pharma AB (publ) across 3 annual periods. Explore LARK capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Novakand Pharma AB (publ) (2012–2021)
Year-by-year Free Cash Flow Generation Index for Novakand Pharma AB (publ). For the full cash flow conversion analysis, see cash efficiency ratio of Novakand Pharma AB (publ).
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.99x | Skr21.97 Million | Skr22.11 Million | Skr147.73K | ▲ +211.6% |
| 2018 | -0.89x | Skr-202.60K | Skr227.60K | Skr430.20K | ▼ -189.0% |
| 2012 | 1.00x | Skr59.21K | Skr59.21K | Skr0.00 | — |